Patients should make well informed decisions

interpreted results appropriately. Patients should make well-informed decisions regarding their
health care and preventative screening options. Patients should be counseling on the risks and

RUNNING HEAD: Prostate-Specific Antigen 5
benefits of prostate cancer screening exam. Educating the patient, especially high-risk patients,
on preventative screenings, such as the prostate-specific antigen test, assists them in making
educated decisions. Empowering our patients allows for early diagnosis, early treatment, and
increased quality of life.
References

RUNNING HEAD: Prostate-Specific Antigen 6
Adhyam, M., & Gupta, A. K. (2012). A Review on the Clinical Utility of PSA in Cancer
Prostate. Indian journal of surgical oncology, 3(2), 120–129. doi:10.1007/s13193-012-
0142-6
American Cancer Society. (2019). Key Statistics for Prostate Cancer. Retrieved from
Arcangelo, V. P., Peterson, A. M., Wilbur, V., & Reinhold, J. A. (Eds.). (2017).
Pharmacotherapeutics for advanced practice: A practical approach (4th ed.). Ambler,
PA: Lippincott Williams & Wilkins.
Chun, C. (2017). What’s Free PSA and How Is It Used to Diagnose Prostate Cancer? Healthline.
Retrieved from
Dains, J. E., Baumann, L. C., & Scheibel, P. (2019). Advanced health assessment and clinical
diagnosis in primary care (6th ed.). St. Louis, MO: Elsevier Mosby.
Mayo Clinic. (2018). Prostate Cancer. Retrieved from -
conditions/prostate-cancer/symptoms-causes/syc-20353087
Prostate Cancer Foundation. (2019). Prostate Cancer Diet. Retrieved from
Seaman, A. (2014). Test for prostate cancer 'does more harm than good.’ Irish Examiner .
Retrieved from -
more-harm-than-good-295479.html